Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

OBJECTIVE: Coagulopathy is one of the characteristics observed in critically ill patients with coronavirus disease 2019 (COVID‐19). Antiphospholipid antibodies (aPLs) contribute to coagulopathy, though their role in COVID‐19 remains unclear. This study was undertaken to determine the prevalence and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Arthritis Rheumatol
Main Authors: Xiao, Meng, Zhang, Yan, Zhang, Shulan, Qin, Xuzhen, Xia, Peng, Cao, Wei, Jiang, Wei, Chen, Huan, Ding, Xin, Zhao, Hua, Zhang, Hongmin, Wang, Chunyao, Zhao, Jing, Sun, Xuefeng, Tian, Ran, Wu, Wei, Wu, Dong, Ma, Jie, Chen, Yu, Zhang, Dong, Xie, Jing, Yan, Xiaowei, Zhou, Xiang, Liu, Zhengyin, Wang, Jinglan, Du, Bin, Qin, Yan, Gao, Peng, Lu, Minya, Hou, Xin, Wu, Xian, Zhu, Huadong, Xu, Yingchun, Zhang, Wen, Li, Taisheng, Zhang, Fengchun, Zhao, Yongqiang, Li, Yongzhe, Zhang, Shuyang
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2020
Teme:
COVID‐19
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7361932/
https://ncbi.nlm.nih.gov/pubmed/32602200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41425
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki